Perrigo's generic dermatitis drug gains FDA nod

08/1/2013 | Drug Store News

Perrigo obtained federal approval for its fluticasone propionate lotion in the 0.05% strength to address inflammatory and pruritic manifestations of atopic dermatitis in pediatric patients ages 1 and older. The drug is a generic copy of PharmaDerm's Cutivate.

View Full Article in:

Drug Store News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC